|
PRPF8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.024000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.032600E-01 |
| Normal-vs-Stage2 |
6.834400E-01 |
| Normal-vs-Stage3 |
8.406000E-01 |
| Normal-vs-Stage4 |
4.994400E-02 |
| Stage1-vs-Stage2 |
7.941200E-01 |
| Stage1-vs-Stage3 |
9.269200E-01 |
| Stage1-vs-Stage4 |
1.676610E-01 |
| Stage2-vs-Stage3 |
8.941000E-01 |
| Stage2-vs-Stage4 |
2.529200E-01 |
| Stage3-vs-Stage4 |
2.865600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.608200E-01 |
| Normal-vs-AfricanAmerican |
1.113240E-01 |
| Normal-vs-Asian |
1.115430E-01 |
| Caucasian-vs-AfricanAmerican |
1.121230E-01 |
| Caucasian-vs-Asian |
4.700000E-01 |
| AfricanAmerican-vs-Asian |
6.465600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.352400E-01 |
| Normal-vs-Female |
1.562780E-01 |
| Male-vs-Female |
3.157700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.508800E-01 |
| Normal-vs-Extreme_Weight |
2.265000E-01 |
| Normal-vs-Obese |
4.809600E-01 |
| Normal-vs-Extreme_Obese |
7.114200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.079000E-01 |
| Normal_Weight-vs-Obese |
1.228410E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.589600E-01 |
| Extreme_Weight-vs-Obese |
1.173210E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.514800E-01 |
| Obese-vs-Extreme_Obese |
4.604200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.147200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.141000E-01 |
| Normal-vs-Age(61-80Yrs) |
8.351700E-02 |
| Normal-vs-Age(81-100Yrs) |
7.601500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.758800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.389700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.396200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.766480E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.250200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.342000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.541200E-01 |
| Normal-VS-Type2 PRCC |
1.133960E-01 |
| Normal-VS-KIRP CIMP |
5.767800E-01 |
| Normal-VS-Unclassified PRCC |
1.925950E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.756000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.790600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.182600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.407400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.256000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.920800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.713900E-02 |
| Normal-vs-N1 |
7.117800E-01 |
| Normal-vs-N2 |
7.482000E-02 |
| N0-vs-N1 |
4.244800E-01 |
| N0-vs-N2 |
7.937600E-01 |
| N1-vs-N2 |
4.869200E-01 |
|
|
